Cyprus/Greece/MaltaCyprusGreeceMalta

Stem cell cluster

03.11.2008

Athens/Houston – Greece is planning to establish state-of-the-art clinics for stem cell therapy with associated stem cell banks. In mid-August, GloCal Investment Ventures Enterprise (G.I.V.E.) – a venture capital fund backed by the Greek governement’s TANEO fund and managed by GloCal Systems Management (GSM) – announced that it had begun negotiations with US-based adult stem cell spec­ialist Stematix Inc. (Houston). Stematix offers fast-tracking from bone marrow to other allogeneic (cross-patient) adult stem cell treatments that make use of umbilical cord blood and placental cells. The plan to establish fully-operational adult stem cell banks and therapy clinics in Greece as a new venture emerged after a US-Greek meeting in July of 2008.

Cyprus/Greece/MaltaCyprusGreeceMalta

06.03.2005

Athens - A three-day conference covering all issues of biotechnology at both fundamental and application level will be held in July this year in Athens: “2nd International Greek Biotechnology Forum - IGBF2”. The event aims at...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Athens - The Greek agriculture minister recently announced that the country will destroy over 9,000 acres of fields planted with biotech-mixed cotton. The Greek government will pay affected farmers an estimated Euro4 million....

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Heraklion/Paris - Together with French Vaxon-Biotech S.A. the Herak-lion University Hospital in Crete has completed the phase I trial of Vaxon's candidate vaccine VX-001, which contains a single optimized cryptic peptide that...

Cyprus/Greece/MaltaCyprusGreeceMalta

13.11.2004

Athens - The Hellenic Innovation Centre presented a new technology in October that enables the production of high-grade pharmaceutical raw material like Inter-feron- and - , Erythropoietin, FSH, and HGH, without unwanted...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.10.2004

Heraklion - The recent research advances on lymphocytes, the most sophisticated of all mature hematopoietic cell types, will be presented during the 2nd Gene Regulation in Lymphocyte Develop-ment Workshop to be held on October...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Valetta - Further to the launch of its DNA Forensics division in February 2004, Synergene Profiling, a subsidiary of the Synergene Biotechnology Group, has successfully completed its first DNA forensic cases.Contracted on behalf...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Athens - The Helenic Society for the Study and Applications of Growth Hormones will hold the 2nd International Congress on Adult Consequences of Childhood Endocrine Diseases from May 6-8 in Athens. Main topics are going to be the...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.04.2004

Attard - The international network Gendia has recently developed a new fast pre-natal test for the most common aneuploidies by quantitative fluorescent PCR (QF-PCR). Gendia was founded last year by the Malta-based biotech company...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.03.2004

Rhodos - SEED ECOLOGY 2004, the first thematic, scientific conference devoted exclusively to seeds and the environment, will take place in Rhodos (April 25 to May 1). The scientific program will cover all aspects of seed eco-logy...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Athens - Biovista recently announced he licensing of its Journal Research AnalystTM (JRA) market intelligence tool by Upstate, Chalottesville/USA, one of the leading suppliers of cell signaling reagents and kinase screening...

Displaying results 31 to 40 out of 47

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/3/article/stem-cell-cluster.html

Stock list

All quotes

TOP

  • CHRONTECH PHARMA (S)0.08 SEK14.29%
  • PROTHENA PLC (IE)18.44 USD6.84%
  • WILEX (D)3.28 EUR5.47%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • HYBRIGENICS (F)1.71 EUR-8.56%

TOP

  • WILEX (D)3.28 EUR349.3%
  • SANTHERA (CH)69.50 CHF114.8%
  • ADDEX (CH)4.21 CHF92.2%

FLOP

  • MERCK KGAA (D)63.45 EUR-51.0%
  • THROMBOGENICS (B)8.55 EUR-47.3%
  • VERONA PHARMA (UK)1.12 GBP-46.2%

TOP

  • SANTHERA (CH)69.50 CHF3410.1%
  • GW PHARMACEUTICALS (UK)415.25 GBP756.2%
  • SKYEPHARMA PLC (UK)260.00 GBP314.3%

FLOP

  • EVOCUTIS (UK)0.21 GBP-92.2%
  • CYTOS (CH)0.27 CHF-92.1%
  • THROMBOGENICS (B)8.55 EUR-72.5%

No liability assumed, Date: 21.07.2014


Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...

Current issue

All issues

Product of the week

Products

Events

All Events